CeriBell (CBLL) Competitors $26.31 +1.08 (+4.28%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends CBLL vs. NARI, LIVN, TMDX, ENOV, SLNO, WRBY, IRTC, CNMD, TNDM, and NVCRShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include Inari Medical (NARI), LivaNova (LIVN), TransMedics Group (TMDX), Enovis (ENOV), Soleno Therapeutics (SLNO), Warby Parker (WRBY), iRhythm Technologies (IRTC), CONMED (CNMD), Tandem Diabetes Care (TNDM), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. CeriBell vs. Inari Medical LivaNova TransMedics Group Enovis Soleno Therapeutics Warby Parker iRhythm Technologies CONMED Tandem Diabetes Care NovoCure CeriBell (NASDAQ:CBLL) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends, valuation and community ranking. Is CBLL or NARI more profitable? CeriBell has a net margin of 0.00% compared to Inari Medical's net margin of -13.68%. CeriBell's return on equity of 0.00% beat Inari Medical's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Inari Medical -13.68%-10.09%-6.60% Do institutionals and insiders believe in CBLL or NARI? 91.0% of Inari Medical shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in CBLL or NARI? Inari Medical received 59 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 61.90% of users gave Inari Medical an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes6100.00% Underperform VotesNo VotesInari MedicalOutperform Votes6561.90% Underperform Votes4038.10% Do analysts recommend CBLL or NARI? CeriBell presently has a consensus price target of $31.20, indicating a potential upside of 18.59%. Inari Medical has a consensus price target of $58.89, indicating a potential upside of 18.58%. Given CeriBell's stronger consensus rating and higher probable upside, research analysts plainly believe CeriBell is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Inari Medical 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Which has better earnings and valuation, CBLL or NARI? CeriBell has higher earnings, but lower revenue than Inari Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$60.04M15.70N/AN/AN/AInari Medical$493.63M5.89-$1.64M-$1.35-36.78 Does the media favor CBLL or NARI? In the previous week, CeriBell had 3 more articles in the media than Inari Medical. MarketBeat recorded 11 mentions for CeriBell and 8 mentions for Inari Medical. Inari Medical's average media sentiment score of 1.03 beat CeriBell's score of 0.60 indicating that Inari Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inari Medical 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCeriBell beats Inari Medical on 9 of the 14 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$942.53M$3.46B$5.38B$8.84BDividend YieldN/A1.70%5.13%4.09%P/E RatioN/A18.72102.4617.58Price / Sales15.7067.101,234.85158.43Price / CashN/A47.0740.4736.33Price / BookN/A4.047.096.50Net IncomeN/A$89.83M$119.65M$226.22M7 Day Performance-0.83%0.51%2.06%3.76%1 Month PerformanceN/A6.35%-2.46%4.63%1 Year PerformanceN/A21.27%33.95%29.20% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBellN/A$26.31+4.3%$31.20+18.6%N/A$942.53M$60.04M0.00N/AQuiet Period ExpirationNARIInari Medical3.2832 of 5 stars$49.80+1.6%$58.89+18.3%-15.9%$2.92B$493.63M-37.071,300Insider TradeLIVNLivaNova4.2267 of 5 stars$51.70+3.3%$69.17+33.8%+16.5%$2.81B$1.15B119.172,900Positive NewsTMDXTransMedics Group4.3375 of 5 stars$79.34+2.8%$131.80+66.1%+10.3%$2.66B$241.62M82.13210Analyst ForecastENOVEnovis3.3705 of 5 stars$46.27+3.3%$67.00+44.8%-8.1%$2.59B$1.71B-20.906,550News CoveragePositive NewsSLNOSoleno Therapeutics4.3263 of 5 stars$54.99+0.3%$74.83+36.1%+106.4%$2.37BN/A-16.5530WRBYWarby Parker2.3874 of 5 stars$23.27flat$18.82-19.1%+118.5%$2.37B$669.77M-86.193,491Analyst ForecastIRTCiRhythm Technologies2.9571 of 5 stars$74.24+0.7%$108.50+46.2%-14.8%$2.32B$492.68M-15.272,000CNMDCONMED4.5862 of 5 stars$71.58+1.3%$79.80+11.5%-30.5%$2.21B$1.24B17.004,000Positive NewsTNDMTandem Diabetes Care4.769 of 5 stars$30.74+2.0%$54.25+76.5%+61.8%$2.02B$747.72M-15.622,400Insider TradeNews CoveragePositive NewsNVCRNovoCure3.8577 of 5 stars$17.09+1.4%$26.17+53.1%+48.7%$1.85B$509.34M-11.961,453Analyst ForecastNews Coverage Related Companies and Tools Related Companies Inari Medical Alternatives LivaNova Alternatives TransMedics Group Alternatives Enovis Alternatives Soleno Therapeutics Alternatives Warby Parker Alternatives iRhythm Technologies Alternatives CONMED Alternatives Tandem Diabetes Care Alternatives NovoCure Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBLL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
